United Therapeutics authorizes additional $420M share repurchase program United Therapeutics announced that its board authorized the repurchase of up to an additional $420M of the company's common stock. This program will become effective on March 4 and will remain open for up to one year.
News For UTHR From The Last 14 Days
Check below for free stories on UTHR the last two weeks.